Hydrea 500 mg Capsules – Hydroxyurea Oral Antineoplastic & Sickle Cell Therapy

EGP3500

NameHydrea 500 mg Kapsul
BrandBristol-Myers Squibb
Strength500 mg
Quantity / Size100 Capsules (per box)
FormCapsules
AppearanceOpaque white hard gelatin capsules
Expiry Date8/2028
Country of OriginTurkey
Product CodeHYD500CAP

Hydrea 500 mg Kapsul contains hydroxyurea, used in the treatment of chronic myelogenous leukemia, polycythemia vera, and sickle cell disease. Prescription only.
SKU: 8699525156679 Category: Tag:
Description

1. Introduction to Hydrea 500 mg Capsules

Hydrea (hydroxyurea) is a locked prescription medication taken orally. It works by inhibiting DNA synthesis via ribonucleotide reductase blockade, slowing the proliferation of blood and cancer cells. Hydrea is an FDA-approved generic and essential medicine used widely since 1967.

2. Therapeutic Uses

  • Chronic Myelogenous Leukemia (CML): Hydrea helps reduce leukemic cell counts .

  • Sickle Cell Disease (SCD): Boosts fetal hemoglobin production, reducing painful vaso‑occlusive crises and transfusion needs in children and adults.

  • Head & Neck Cancer: Often combined with radiation for squamous cell carcinomas.

  • Other Myeloproliferative Disorders: Used in essential thrombocythemia, polycythemia vera, and occasionally psoriasis (Wikipedia).

  • Melanoma research: Emerging data suggests potential in certain melanomas via miRNA modulation .

3. Mechanism of Action

Hydrea inhibits ribonucleotide reductase, arresting cell cycle in G1/S phase and enhancing radiosensitivity. In SCD, it elevates fetal hemoglobin (HbF) to reduce sickling.

4. Dosage & Administration

  • Starting dose for adults with normal renal function: approx. 15 mg/kg once daily.

  • Renal impairment (CrCl <60 mL/min): dose reduced by 50% (≈ 7.5 mg/kg).

  • Pediatric care: Customized to body weight; tablets/capsules taken whole, with/without food .

Explore more: Natrol Acidophilus Probiotic 1 Billion (150 ct) – Digestive & Immune Support Supplement

5. Monitoring & Safety Precautions

  • Bone marrow suppression: Frequent CBCs before and during treatment to monitor WBCs, platelets, RBCs.

  • Infection risk: Watch for fevers, chills, sore throat .

  • Secondary malignancies: Rare skin cancer or leukemia risk with long-term use .

  • Pregnancy & fertility: Teratogenic; contraception recommended for 6 months post‑therapy in both genders.

  • Vaccinations: Avoid live vaccines while on therapy .

  • Sun protection: Use sunscreen; avoid excessive sun exposure.

6. Common & Serious Side Effects

Side Effect TypeExamples
CommonLow blood counts, nausea, loss of appetite, headache, constipation, mouth sores
SeriousFever/infections, bleeding/bruising, black/tarry stools, dyspnea, skin ulcers or gangrene

If serious symptoms appear, stop Hydrea and seek medical attention immediately.

Explore more: Horbaach Vitamin D3 5000 IU + K2 MK-7 100 mcg | High Potency 180 Softgels

7. Handling & Storage

  • Handle with care; avoid contact if pregnant or via caregivers (use gloves).

  • Store at 15–30 °C, tightly sealed in original packaging, out of children’s reach.

8. Drug Interactions & Contraindications

  • Contraindicated: severe bone marrow depression, prior hypersensitivity, severe anemia, during pregnancy.

  • Interactions: other myelosuppressive agents or recent radiation increase marrow toxicity risk; adjust dose accordingly.

9. Why Choose Hydrea?

  • Well‑studied with 50+ years of use.

  • Generic & essential medicine – high cost‑effectiveness.

  • Versatile indications include sickle cell, CML, head/neck cancers, etc.


✅ FAQs

Q1: How long does it take for Hydrea to reduce sickle‑cell crises?
A: Most patients observe fewer painful crises and transfusion needs within 2–4 months of consistent dosing.

Q2: Can Hydrea be used during pregnancy?
A: No—Hydrea is teratogenic. Effective contraception is required during treatment and for 6 months after therapy ends.

Q3: What types of blood monitoring are needed?
A: Complete blood counts (CBC) are done weekly during initiation, then monthly once stabilized to watch for cytopenias .

Q4: Can Hydrea cause hair loss or skin ulcers?
A: Yes. Hair thinning, nail discoloration, and rare skin ulcers/gangrene have been reported—contact your physician if skin lesions occur.

Q5: Could Hydrea increase the risk of other cancers?
A: Long-term use in myeloproliferative disorders has a small risk of secondary leukemia or skin cancer—regular skin checks are advised.

Explore more at No style Like : Cancer treatment drugs


User Reviews

  • ⭐⭐⭐⭐⭐ Very effective for SCD “After starting Hydrea, my child hasn’t had a pain crisis in over four months—life‑changing!”

  • ⭐⭐⭐⭐ Good for leukemia but tough monitoring “It helps control my CML, but I do worry about frequent blood tests.”

  • ⭐☆☆☆☆ Caused mouth ulcers “I developed painful mouth sores and had to pause treatment.”